1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Allied Healthcare Products, Inc.

Allied Healthcare Products, Inc.

AHPIQ
Allied Healthcare Products, Inc.US flagOther OTC
0.00
USD
+0.00
- -
4,010.00Market Cap
Allied Healthcare Products, Inc.
AHPIQ
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
FRC
14.35
14.3
13.18
11.41
11.54
10.7
9.55
9.06
8.84
8.96
8.35
8.41
7.82
7.95
9.04
6.74
6.74
Revenue per Share
0.42
0.22
-4.24
-0.15
0.05
-0.1
-0.31
-0.7
-0.44
-0.57
-0.52
-0.55
-0.53
-0.75
0.42
-1.34
-1.34
Basic EPS, GAAP
0.21
0.64
-0.69
0.87
0.36
0.24
0.01
-0.47
0.2
-0.06
-0.17
-0.21
0.01
0.16
-0.94
-1.02
-1.02
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
4.01
4.2
-0.05
-0.2
-0.15
-0.25
-0.57
-1.27
-1.71
-2.3
-2.82
-3.37
-3.89
-4.64
-4.22
-5.56
-5.56
Book Value per Share
6.73
6.94
6.76
6.65
6.7
6.59
6.27
5.61
5.16
4.55
4.03
3.49
2.96
2.21
2.64
1.3
1.3
Tangible Book Value per Share
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
Basic Weighted Avg Shares
57
56
52
46
47
43
39
36
35
36
34
34
31
32
36
27
27
Sales/Revenue/Turnover
4.29
2.26
-2.39
-1.7
0.87
-1.5
-6.47
-8.55
-4.78
-5.34
-6.12
-5.91
-8.84
-9.6
-1.45
-16.93
-16.93
Operating Margin (%)
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
- -
- -
Depreciation Expense
2
1
-17
-1
- -
- -
-1
-3
-2
-2
-2
-2
-2
-3
2
-5
-5
Net Income, GAAP
35.77
33.71
- -
- -
43.76
- -
- -
- -
- -
- -
- -
- -
- -
- -
4.12
- -
- -
Effective Tax Rate (%)
2.91
1.57
-32.19
-1.3
0.44
-0.98
-3.26
-7.71
-5.01
-6.41
-6.23
-6.49
-6.72
-9.45
4.65
-19.82
-19.82
Profit Margin (%)
17
18
17
18
18
16
14
11
11
11
10
9
7
6
6
10
10
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
LT Debt
42
43
27
27
27
27
25
23
21
18
16
14
12
9
11
5
5
Total Equity
3.67
1.94
- -
- -
0.84
- -
- -
- -
- -
- -
- -
- -
- -
- -
-4.28
- -
- -
Return on Invested Capital (%)
10.98
5.46
- -
- -
-28.77
- -
- -
- -
- -
- -
- -
- -
- -
- -
-11.57
- -
- -
Return on Capital (%)
10.98
5.46
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'22
Mar'22
Jun'22
ST Debt
3
3
2
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4
4
4
Market Capitalization
23
13
7

Working Capital

FRC

•

in mil. unless spec.
Dec'22
Mar'22
Jun'22
Total Current Assets
12
12
16
Cash, Cash Equivalents & STI
- -
- -
3
Accounts Receivable, Net
2
3
2
Inventories
9
9
8
Total Current Liabilities
7
8
6
Payables & Accruals
3
4
2
ST Debt
3
3
2
Deferred Revenue
1
1
1

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-13.3%
-17.06%
-50.53%
Free Cash Flow
-933.49%
46.68%
8.25%
Net Income, GAAP
-22.67%
-105.94%
-417.77%
Sales/Revenue/Turnover
-4.12%
-3.28%
-25.45%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
8
7
8
9
32
2021
10
11
8
7
36
2022
7
7
7
6
27

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
-0.15
-0.38
-0.08
- -
-0.75
2021
-0.04
0.17
-0.1
- -
0.42
2022
-0.25
-0.29
-0.32
- -
-1.34

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
Similar Companies
Bioptik Technology Incorporation (4161.TWO)
BICO Group AB (publ) (CLLKF)
Siemens Healthineers AG (SEMHF)
Anika Therapeutics, Inc. (ANIK)
EOFLOW Co.,Ltd. (294090.KQ)
Venus Concept Inc. (VERO)
Business
Allied Healthcare Products, Inc. was a key producer and distributor of medical devices serving the global healthcare sector across various settings, including hospital facilities and alternative care environments. The company's comprehensive portfolio encompassed a wide array of respiratory care and anesthesia solutions, featuring items such as air compression units, calibration tools, humidification devices, and equipment for respiratory disposables like oxygen lines, facial masks, and ventilation circuits. They also provided home respiratory support products, which included lightweight oxygen tanks, regulators, pneumatic nebulizers, and portable suction apparatus. Furthermore, the organization specialized in medical gas infrastructure, offering components for in-wall gas systems, central station pumps and compressors, and integrated headwall units. Its regulation and suction instruments, such as flowmeters, vacuum controls, and pressure regulators, along with corresponding adapters and hoses, were designed to measure, manage, monitor, and deliver medical gases from piped systems or machinery directly to patients in hospital rooms, surgical suites, and intensive care areas. Disposable oxygen containers for short-term oxygen delivery were also part of their offerings. In the emergency medical field, Allied Healthcare Products supplied critical respiratory and resuscitation equipment, including demand resuscitation valves, portable resuscitation kits, bag masks, emergency transport ventilators, and precision oxygen regulators. Their trauma and patient handling product lines featured spinal immobilization devices, pneumatic anti-shock garments, and trauma burn treatment kits. The company historically served hospitals, equipment distributors, construction contractors for healthcare facilities, home health care providers, and emergency medical product vendors. Established in 1979 and previously headquartered in Chicago, Illinois, the enterprise faced severe liquidity challenges. Consequently, Allied Healthcare Products, Inc. initiated voluntary reorganization proceedings under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of Missouri on May 8, 2023. This process aimed for an orderly sale of its business. Subsequently, the company was acquired by Allied Medical LLC (operating as Flexicare) through a Section 363 sale, with the transaction concluding on July 12, 2023. An amended liquidation plan was officially approved by the U.S. Bankruptcy Court on January 19, 2024. The company definitively ceased operations as its liquidation plan became effective on February 5, 2024.